Progressive ratio test 2 inactive lever presses

Tags: Behavior · Motivation · Progressive ratio

Project: p50_paul_meyer_2020

3 loci · 3 genes with independent associations · 3 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 1 84591076 85984018 1 1 3.46e-07 7.76e-03 3.43e-01 Zfp14
2 8 108584253 109479622 1 1 4.42e-12 5.20e-03 2.46e-04 Apeh
3 11 39057816 40174684 1 1 5.69e-09 1.06e-01 1.00e+00 Epha6

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
Body weight 1.89 1 0 0 0 1.00e+00 Zfp14
Heart weight 4.41 1 0 0 0 1.00e+00 Epha6
Left kidney weight 6.11 1 0 0 0 1.00e+00 Zfp14
Right kidney weight 5.73 1 0 0 0 1.00e+00 Zfp14
Liver weight, left 3.97 1 0 0 0 1.00e+00 Apeh
Parametrial fat weight 15.44 2 1 33.3 0 1.00e+00 Epha6 Zfp14
Intraocular pressure 5.23 1 0 0 0 1.00e+00 Epha6
Tibia length 2.39 1 0 0 0 1.00e+00 Epha6
Food consumed during 24 hour testing period 5.68 1 0 0 0 1.00e+00 Epha6
Times rat made contact with spout 14.73 1 0 0 0 1.00e+00 Epha6
Std. dev. time between licks in bursts 6.89 1 0 0 0 1.00e+00 Apeh
Water consumed over 24 hours 15.6 1 0 0 0 1.00e+00 Epha6
Indifference point AUC 7.37 1 0 0 0 1.00e+00 Zfp14
Delay discounting total patch changes 12 sec 11.65 1 0 0 0 1.00e+00 Epha6
Delay discounting total patch changes 18 sec 10.73 2 0 0 0 1.00e+00 Epha6 Apeh
Delay discounting total patch changes 6 sec 9.33 2 0 0 0 1.00e+00 Epha6 Apeh
Delay discounting water rate 18 sec 10.64 2 0 0 0 1.00e+00 Epha6 Zfp14
Delay discounting water rate 24 sec 15.39 1 0 0 0 1.00e+00 Zfp14
Locomotor activity 6.32 2 0 0 0 1.00e+00 Epha6 Zfp14
Locomotor testing distance 7.95 1 0 0 0 1.00e+00 Epha6
Reaction time premature initiation rate 8.75 1 0 0 0 1.00e+00 Epha6
Reaction time premature initiations 5.85 1 0 0 0 1.00e+00 Epha6
Conditioned locomotion 14.73 1 0 0 0 1.00e+00 Epha6
Cocaine response before conditioning 7.22 2 0 0 0 1.00e+00 Epha6 Zfp14
Condit. Reinf. lever presses 6.01 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. lever latency 5.89 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. lever contacts 7.02 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. magazine entry number 6.55 1 0 0 0 1.00e+00 Epha6
Conditioned reinforcement - actives 21.15 1 0 0 0 1.00e+00 Epha6
Conditioned reinforcement - inactives 24.8 3 2 66.7 1 9.09e-04 Epha6 Apeh Zfp14
Conditioned locomotion 6.29 2 0 0 0 1.00e+00 Apeh Zfp14
Intermittent access intake day 1-15 change 26.8 1 1 33.3 0 1.00e+00 Apeh
Intermittent access intake escalation 21.18 1 0 0 0 1.00e+00 Apeh
Intermittent access intake escalation 2 29.8 1 1 33.3 0 1.00e+00 Apeh
Intermitt. access day 15 inactive lever presses 27.39 1 1 33.3 0 1.00e+00 Apeh
Intermitt. access escalation Index 7.17 1 0 0 0 1.00e+00 Zfp14
Intermittent access day 1 total infusions 11.97 2 0 0 0 1.00e+00 Epha6 Zfp14
Intermittent access day 15 total infusions 13.11 2 0 0 0 1.00e+00 Epha6 Zfp14
Intermittent access terminal intake (last 3 days) 19.74 2 0 0 0 1.00e+00 Epha6 Zfp14
Intermittent access total infusions 16.84 2 0 0 0 1.00e+00 Epha6 Zfp14
Intermittent access day 1 locomotion 8.99 1 0 0 0 1.00e+00 Zfp14
Intermittent access standard deviation 34.31 1 1 33.3 0 1.00e+00 Apeh
Cocaine induced anxiety 12.4 2 0 0 0 1.00e+00 Epha6 Apeh
Post-drug Anxiety 5.89 1 0 0 0 1.00e+00 Epha6
Baseline Anxiety 18.76 1 0 0 0 1.00e+00 Epha6
Lifetime Intake 24.09 2 1 33.3 0 1.00e+00 Epha6 Zfp14
Incentive Sensitization - Responses 9.08 2 0 0 0 1.00e+00 Epha6 Apeh
Incentive Sensitization - Breakpoint 8.82 2 0 0 0 1.00e+00 Epha6 Apeh
Progressive ratio test 1 active lever presses 17.81 3 1 33.3 0.61 3.93e-01 Epha6 Apeh Zfp14
Progressive ratio test 1 breakpoint 19.6 3 1 33.3 0.62 3.76e-01 Epha6 Apeh Zfp14
Progressive ratio test 1 inactive lever presses 8.95 2 0 0 0 1.00e+00 Epha6 Apeh
Progressive ratio test 2 active lever presses 23.5 2 1 33.3 0 1.00e+00 Epha6 Zfp14
Progressive ratio test 2 breakpoint 18.15 2 1 33.3 0 1.00e+00 Epha6 Zfp14
Total sessions with >9 infusions 14.68 2 0 0 0 1.00e+00 Epha6 Apeh
Short access day 1 total inactive lever presses 7.78 3 0 0 0.98 1.95e-02 Epha6 Apeh Zfp14
Short access day 10 total inactive lever presses 40.3 1 1 33.3 0 1.00e+00 Apeh
Short access day 1 total infusions 37.11 1 1 33.3 0 1.00e+00 Epha6
Short access day 10 total infusions 6.17 1 0 0 0 1.00e+00 Zfp14
Short access total infusions 40.36 1 1 33.3 0 1.00e+00 Epha6
Short access day 10 total locomotion 6.38 1 0 0 0 1.00e+00 Apeh
Short access total locomotion 10.65 1 0 0 0 1.00e+00 Apeh
Compulsive drug intake 7.66 1 0 0 0 1.00e+00 Apeh
One hour access (0.3 mA shock) 24.94 2 1 33.3 0 1.00e+00 Epha6 Zfp14
One hour access (shock baseline) 16.75 2 0 0 0 1.00e+00 Epha6 Zfp14
Number of responses in last shaping day 12 1 0 0 0 1.00e+00 Apeh
Locomotion distance, session 1 10.11 1 0 0 0 1.00e+00 Epha6
Stereotopy head waving bouts, day 3 8.94 1 0 0 0 1.00e+00 Epha6
Locomotion velocity, session 7 6.82 1 0 0 0 1.00e+00 Epha6
Locomotion distance, session 7 12.27 1 0 0 0 1.00e+00 Epha6
Stereotopy head waving bouts, day 7 5.97 1 0 0 0 1.00e+00 Zfp14
Locomotion distance, session 8 5.02 1 0 0 0 1.00e+00 Epha6
Degree of sensitization stereotypy 11.13 1 0 0 0 1.00e+00 Zfp14
Condit. Reinf. active minus inactive responses 9.43 1 0 0 0 1.00e+00 Epha6
Condit. Reinf. active-inactive response ratio 8.4 1 0 0 0 1.00e+00 Epha6
Condit. Reinf. active responses 7.45 1 0 0 0 1.00e+00 Epha6
Incentive salience index mean 10.79 1 0 0 0 1.00e+00 Epha6
Condit. Reinf. lever presses 8.2 1 0 0 0 1.00e+00 Epha6
Time in familiar zone, hab. session 1 9.26 1 0 0 0 1.00e+00 Epha6
Time in novel zone, hab. session 1 10.19 2 0 0 0 1.00e+00 Epha6 Zfp14
Total zone transitions, hab. session 1 8.13 1 0 0 0 1.00e+00 Epha6
Total locomotion distance, hab. session 1 4.8 1 0 0 0 1.00e+00 Epha6
Locomotion velocity, hab. session 1 8.12 1 0 0 0 1.00e+00 Epha6
Time in familiar zone, hab. session 2 29.91 1 1 33.3 0 1.00e+00 Epha6
Time in novel zone, hab. session 2 25.18 1 1 33.3 0 1.00e+00 Epha6
Total zone transitions, hab. session 2 7.43 1 0 0 0 1.00e+00 Epha6
Total locomotion distance, hab. session 2 7.03 2 0 0 0 1.00e+00 Epha6 Zfp14
Locomotion velocity, hab. session 2 8.08 1 0 0 0 1.00e+00 Epha6
Novel to familiar place preference ratio 6.25 1 0 0 0 1.00e+00 Apeh
Novelty place preference 7.01 1 0 0 0 1.00e+00 Apeh
Time in novel zone, NPP test 6.78 1 0 0 0 1.00e+00 Apeh
Pavlov. Cond. lever latency 14.56 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. magazine entry latency 18.3 3 1 33.3 -0.64 3.61e-01 Epha6 Apeh Zfp14
Pavlov. Cond. change in total contacts 7.31 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. index score 24.26 1 1 33.3 0 1.00e+00 Epha6
Pavlov. Cond. latency score 22.39 1 1 33.3 0 1.00e+00 Epha6
Pavlov. Cond. lever contacts 20.49 1 1 33.3 0 1.00e+00 Epha6
Pavlov. Cond. magazine entry number 12.84 1 0 0 0 1.00e+00 Epha6
Pavlov. Cond. lever-magazine prob. diff. 22.92 1 1 33.3 0 1.00e+00 Epha6
Pavlov. Cond. response bias 18.18 2 1 33.3 0 1.00e+00 Epha6 Apeh
Bone: apparent density 8.43 1 0 0 0 1.00e+00 Zfp14
Bone surface 4.1 2 0 0 0 1.00e+00 Epha6 Zfp14
Bone volume 3.84 1 0 0 0 1.00e+00 Zfp14
Bone: connectivity density 4.88 2 0 0 0 1.00e+00 Epha6 Zfp14
Bone: cortical thickness 13.39 1 0 0 0 1.00e+00 Epha6
Bone: endosteal estimation 3.29 1 0 0 0 1.00e+00 Epha6
Bone: marrow area 2.98 1 0 0 0 1.00e+00 Epha6
Bone: maximum diameter 6.08 1 0 0 0 1.00e+00 Epha6
Bone: periosteal perimeter 4.91 1 0 0 0 1.00e+00 Epha6
Bone: stiffness 6.97 1 0 0 0 1.00e+00 Epha6
Bone: trabecular number 5.43 1 0 0 0 1.00e+00 Zfp14
Breakpoint value in progressive ratio session 11.42 1 0 0 0 1.00e+00 Zfp14
Diff in mean of infusions in LGA sessions 7.96 1 0 0 0 1.00e+00 Zfp14
Time in closed arm before self-admin 7.8 1 0 0 0 1.00e+00 Zfp14
Time in open arm before self-admin 10.65 1 0 0 0 1.00e+00 Zfp14
Time to tail flick, test, before self-admin 6.51 1 0 0 0 1.00e+00 Epha6
Delta time to tail flick, vehicle, before/after SA 8 1 0 0 0 1.00e+00 Epha6
Ambulatory time before self-admin 10.3 1 0 0 0 1.00e+00 Apeh
Area under the delay curve 6.54 1 0 0 0 1.00e+00 Epha6
Delay disc. indifference point, 0s delay 11.52 1 0 0 0 1.00e+00 Epha6
Delay disc. indifference point, 16s delay 7.47 1 0 0 0 1.00e+00 Zfp14
Delay disc. indifference point, 4s delay 9.3 2 0 0 0 1.00e+00 Epha6 Zfp14
Delay disc. indifference point, 8s delay 7.89 1 0 0 0 1.00e+00 Epha6
Delay discount exponential model param 6.64 1 0 0 0 1.00e+00 Epha6
Delay discount hyperbolic model param 6.66 1 0 0 0 1.00e+00 Epha6
Bouts of movement, locomotor time 1 8.93 2 0 0 0 1.00e+00 Epha6 Zfp14
Total resting periods, locomotor time 1 6.51 1 0 0 0 1.00e+00 Zfp14
Vertical activity count, locomotor time 1 7.25 1 0 0 0 1.00e+00 Epha6
Rest time, locomotor task time 2 5.68 1 0 0 0 1.00e+00 Epha6
Seeking ratio, delayed vs. immediate footshock 11.05 1 0 0 0 1.00e+00 Epha6
Locomotion in novel chamber post-restriction 15.32 1 0 0 0 1.00e+00 Epha6
Run reversals in cocaine runway, males 9.58 1 0 0 0 1.00e+00 Zfp14
Latency to leave start box in cocaine runway 8.54 1 0 0 0 1.00e+00 Epha6
Na content in liver 10.19 1 0 0 0 1.00e+00 Epha6
Rb content in liver 9.23 1 0 0 0 1.00e+00 Zfp14
Se content in liver 11.12 1 0 0 0 1.00e+00 Epha6

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.16
Adipose alternative TSS 0 0 1.23
Adipose gene expression 0 0 1.15
Adipose isoform ratio 0 0 1.14
Adipose intron excision ratio 0 0 1.05
Adipose mRNA stability 0 0 1.14
BLA alternative polyA 0 0 1.1
BLA alternative TSS 0 0 1.06
BLA gene expression 0 0 1.17
BLA isoform ratio 0 0 1.15
BLA intron excision ratio 0 0 1.1
BLA mRNA stability 0 0 1.17
Brain alternative polyA 0 0 1.18
Brain alternative TSS 0 0 1.2
Brain gene expression 0 0 1.15
Brain isoform ratio 0 0 1.2
Brain intron excision ratio 0 0 1.11
Brain mRNA stability 0 0 1.17
Eye alternative polyA 0 0 1.5
Eye alternative TSS 0 0 1.18
Eye gene expression 0 0 1.18
Eye isoform ratio 0 0 1.14
Eye intron excision ratio 0 0 1.04
Eye mRNA stability 0 0 1.25
IL alternative polyA 0 0 1.23
IL alternative TSS 0 0 1.18
IL gene expression 0 0 1.19
IL isoform ratio 0 0 1.31
IL intron excision ratio 0 0 1.18
IL mRNA stability 0 0 1.21
LHb alternative polyA 0 0 0.99
LHb alternative TSS 0 0 1.22
LHb gene expression 0 0 1.18
LHb isoform ratio 0 0 1.16
LHb intron excision ratio 0 0 1.08
LHb mRNA stability 0 0 1.17
Liver alternative polyA 0 0 1.08
Liver alternative TSS 0 0 1.22
Liver gene expression 1 0 1.15
Liver isoform ratio 0 0 1.24
Liver intron excision ratio 0 0 1.14
Liver mRNA stability 0 0 1.2
NAcc alternative polyA 0 0 1.06
NAcc alternative TSS 0 0 1.22
NAcc gene expression 0 0 1.17
NAcc isoform ratio 0 0 1.16
NAcc intron excision ratio 0 0 1.1
NAcc mRNA stability 0 0 1.19
OFC alternative polyA 0 0 1.11
OFC alternative TSS 0 0 1.13
OFC gene expression 0 0 1.21
OFC isoform ratio 0 0 1.21
OFC intron excision ratio 0 0 1.13
OFC mRNA stability 0 0 1.15
PL alternative polyA 0 0 1.12
PL alternative TSS 2 0.2 1.24
PL gene expression 0 0 1.18
PL isoform ratio 0 0 1.19
PL intron excision ratio 0 0 1.14
PL mRNA stability 1 0 1.22